Neuroblastoma is relatively serious and is classified as a highly malignant tumor, one of the epithelial cell tumors. The disease often leads to severe intracranial pressure increases, manifesting as intense headaches, dizziness, nausea, vomiting, and even possible optic disc edema, vision loss, and visual field defects. The occurrence of neuroblastoma often indicates a poor prognosis for patients, with a short disease duration and reduced survival time. The five-year survival rate is decreased. Treatment primarily involves surgical intervention to completely remove the neuroblastoma, followed by postoperative radiotherapy, chemotherapy, and other related treatments.